Defunct Company
Total Trials
5
As Lead Sponsor
3
As Collaborator
2
Total Enrollment
655
NCT00800345
Phase I Trial of Oral Metronomic Topotecan and Oral Pazopanib to Treat Recurrent/Persistent Gynecologic Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 30, 2009
Completion: Sep 30, 2015
NCT01388647
Study of Neoadjuvant Carboplatin, Eribulin and Trastuzumab for Operable HER2 Positive Breast Cancer
Phase: Phase 1/2
Start: Aug 31, 2011
Completion: Sep 30, 2014
NCT01506596
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Phase: Phase 2
Start: Mar 31, 2012
Completion: Mar 31, 2016
NCT02906852
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Phase: N/A
Role: Collaborator
Start: Aug 1, 2016
Completion: Dec 31, 2018
NCT03592771
THRIVE Breast Cancer App Study
Start: Nov 15, 2018
Completion: Jun 30, 2022